Group 1 - New Yi Sheng expects a net profit increase of 327.68%-385.47% for the first half of 2025, reaching between 37 billion to 42 billion yuan, driven by growth in AI-related computing power demand and product structure optimization [2][4] - Xinghui Entertainment plans to sell 99.66% of its stake in the Spanish club Espanyol for 1.3 billion euros, with half of the payment in cash and the other half in shares [3] - *ST Yushun intends to acquire 100% of three companies for a total of 33.5 billion yuan, aiming to diversify its business into data center infrastructure services and related products [4] Group 2 - Salted Fish plans to reduce its shareholding by up to 2.04%, with a major shareholder intending to sell 5,455,572 shares [5] - Lian Microelectronics expects a net loss of approximately 1.21 billion yuan for the first half of 2025 [6] - Meinian Health anticipates a net loss of 1.92 billion to 2.36 billion yuan for the first half of 2025, with revenue expected to decline by 0.12%-5.83% [7] Group 3 - Chengdi Xiangjiang forecasts a net profit of 28 million to 42 million yuan for the first half of 2025, marking a turnaround from a loss of 69.29 million yuan in the previous year [8] - Jinpu Titanium plans to acquire 100% of Nanjing Lide Oriental Rubber and Plastic Technology Co., Ltd., with stock resuming trading after the announcement [9] - Bohai Leasing expects a net loss of 1.8 billion to 2.4 billion yuan for the first half of 2025 due to goodwill impairment from a subsidiary's asset sale [10] Group 4 - Foton Motor anticipates a net profit increase of approximately 87.5% for the first half of 2025, reaching about 777 million yuan [11] - Shenwan Hongyuan expects a net profit growth of 92.66%-111.46% for the first half of 2025, estimating profits between 4.1 billion to 4.5 billion yuan [12] - Ganfeng Lithium predicts a net loss of 5.5 billion to 3 billion yuan for the first half of 2025, an improvement from a loss of 7.6 billion yuan in the previous year [13] Group 5 - Suzhou Planning intends to acquire 100% of Beijing Dongjin Aviation Technology Co., Ltd., with stock resuming trading after the announcement [14] - Xiangyang Bearing expects a net loss of approximately 13 million yuan for the first half of 2025, slightly worse than the previous year's loss [15] - Tianqi Lithium forecasts a net profit of 0 to 1.55 billion yuan for the first half of 2025, a significant improvement from a loss of 5.2 billion yuan in the previous year [16] Group 6 - Shandong Gold anticipates a net profit increase of 84.3%-120.5% for the first half of 2025, estimating profits between 2.55 billion to 3.05 billion yuan [17] - Yunnan Geology expects a net profit of 16 million to 23 million yuan for the first half of 2025, marking a turnaround from a loss in the previous year [18] - Four-dimensional Map expects a net loss of 319 million to 268 million yuan for the first half of 2025, with revenue growth of 3.07%-14.30% [19] Group 7 - Tangrenshen anticipates a net loss of 54 million to 69 million yuan for the first half of 2025, a significant decline from the previous year's profit [20] - Changbai Mountain expects a net loss of 2.58 million to 1.58 million yuan for the first half of 2025, with revenue decreasing by approximately 7.48% [21] - Jiu Gui Jiu predicts a net profit of 8 million to 12 million yuan for the first half of 2025, a decline of 90.08%-93.39% compared to the previous year [22] Group 8 - Hengsheng Electronics expects a net profit increase of 740.95% for the first half of 2025, estimating profits around 251 million yuan [23] - Qixia Construction anticipates a net profit of 5.5 million to 8 million yuan for the first half of 2025, driven by increased project completions [24] - Poly Development expects a net profit decrease of 63.15% for the first half of 2025, estimating profits around 27.35 billion yuan [25] Group 9 - Anyuan Coal anticipates a net loss of 259 million to 310 million yuan for the first half of 2025, worsening from the previous year's loss [26] - Zhonghua Equipment plans to acquire 100% of Yiyang Rubber Machine and Beihua Machine, with stock suspension expected for no more than 10 trading days [27] - Bayi Steel expects a net loss of 650 million to 700 million yuan for the first half of 2025, primarily due to weak market conditions [28] Group 10 - Yuegui Co. anticipates a net profit increase of 58.67%-77.12% for the first half of 2025, estimating profits between 215 million to 240 million yuan [29] - Dalian Friendship expects a net loss of 38 million to 30 million yuan for the first half of 2025, with revenue impacted by tax-related issues [30] - Hangfa Power expects a net profit decrease of 84.53%-86.55% for the first half of 2025, estimating profits around 80 million to 92 million yuan [31] Group 11 - Dongfang Zirconium anticipates a net profit increase of 141.77%-156.80% for the first half of 2025, estimating profits between 25 million to 34 million yuan [32] - Hangzhou Steel expects a net profit decrease of 2% from a major shareholder's planned reduction [33] - Jingao Technology predicts a net loss of 2.5 billion to 3 billion yuan for the first half of 2025, worsening from the previous year's loss [34] Group 12 - Shanshan Co. expects a net profit increase of 810.41%-1265.61% for the first half of 2025, estimating profits between 160 million to 240 million yuan [35] - Guocheng Mining anticipates a net profit increase of 1046.75%-1174.69% for the first half of 2025, estimating profits between 493 million to 548 million yuan [36] - Jindi Group expects a net loss of 3.4 billion to 4.2 billion yuan for the first half of 2025, with significant declines in revenue [37] Group 13 - Founder Securities anticipates a net profit increase of 70%-80% for the first half of 2025, estimating profits between 22.96 billion to 24.32 billion yuan [38] - Hasi Lian expects a net loss of 98 million to 80 million yuan for the first half of 2025, a significant decline from the previous year [39] - Lanhua Ketech expects a net profit decrease of 89.12%-92.75% for the first half of 2025, estimating profits between 40 million to 60 million yuan [40] Group 14 - Shanxi Securities anticipates a net profit increase of 58.17%-70.72% for the first half of 2025, estimating profits between 5.04 billion to 5.44 billion yuan [41] - Xinda Real Estate expects a net loss of 3.5 billion to 3.9 billion yuan for the first half of 2025, with significant declines in revenue [42] - Xiangcai Co. anticipates a net profit increase of 63.64%-118.19% for the first half of 2025, estimating profits between 12 million to 16 million yuan [43] Group 15 - Longi Green Energy expects a net loss of 2.4 billion to 2.8 billion yuan for the first half of 2025, despite an increase in sales volume [44] - Wentai Technology anticipates a net profit increase of 178%-317% for the first half of 2025, estimating profits between 390 million to 585 million yuan [45] - Ruida Futures expects a net profit increase of 50.56%-83.15% for the first half of 2025, estimating profits between 206 million to 251 million yuan [46] Group 16 - Debang Co. anticipates a net profit decrease of 84.26%-87.86% for the first half of 2025, estimating profits between 40 million to 52 million yuan [47] - Jin Yi Culture expects a net loss of 20 million to 32 million yuan for the first half of 2025, a significant decline from the previous year [48] - Hongdian Film expects a net profit increase of 103.55%-160.09% for the first half of 2025, estimating profits between 180 million to 230 million yuan [49] Group 17 - Qiaqia Food anticipates a net profit decrease of 71.05%-76.25% for the first half of 2025, estimating profits between 80 million to 97.5 million yuan [50] - Guotai Haitong expects a net profit increase of 205%-218% for the first half of 2025, estimating profits between 15.283 billion to 15.957 billion yuan [51] - Xining Special Steel expects a net loss of approximately 234 million yuan for the first half of 2025, with revenue impacted by low steel prices [52]

近日，北京美年健康（002044）公益基金会(以下简称：美年健康公益基金会)第一届理事会第一次会议 在宁波召开。会议全程严格遵循法定程序，审议通过基金会章程，选举产生基金会理事长、副理事长、 秘书长和监事，审议通过基金会2025年下半年工作规划，以规范化运作为基础，标志着美年健康公益基 金会正式开始运营。 根据规划，基金会将锚定四大公益方向精准发力：在弱势群体健康关爱领域，持续深耕"爱无疆公益助 残"、"打工妈妈健康关爱"、"退役军人健康关爱"、"新业态劳动者健康关爱"、"爱老敬老健康关 爱"及"乡村教师健康关爱"等六大公益IP，通过专业化、系统化的服务，为困境群体筑牢健康保障；聚 焦疾病早筛攻坚，启动阿尔茨海默病早筛公益项目；在健康知识科普方面，整合三甲医院权威专家资 源，打造高质量健康科普品牌"美年健康专家课"；在健康生活方式倡导领域，依托"美年健康益起跑"小 程序，创新采用公益跑里程兑换体检服务模式，深度融合运动健康、公益慈善与个人健康管理理念，推 动全民健康意识提升。 美年健康表示，美年健康公益基金会的成立，既是集团积极响应健康公益行业共识的重要举措，更 让"大健康即公益"的理念有了实体载体。美年健康 ...

在当今快速发展的商业环境下，中小企业作为我国经济的重要有生力量，承载着创新发展与促进经济稳定的重任，同 时也面临着诸多不确定性和潜在风险。美年健康凭借其在健康体检和健康管理领域的深厚积累与亿级健康大数据的规 模发展，近日正式推出专为中小型企业定制的团体意外保障方案——"美企保"。 该产品基于亿级规模的健康体检大数据，创新性地将健康体检、疾病预防与风险保障深度融合，专为美年健康企业客 户量身定制，全面覆盖企业体检客户的基础风险，构筑企业员工健康保障的第二道"防火墙"。 据了解，"美企保"突破传统团险框架，以百万级保额和广泛保障范围构筑全场景安全网，重塑企业风险对冲能力。例 如，意外伤残及身故最高保额50万，公共交通工具导致的相关情况最高保额达100万，意外医疗报销额度最高50万， 猝死保障最高25万，还有每日最高 100元的意外住院津贴；同时具备五大特色，行业标准更高、起保人数要求低、职 业分类精细、医院覆盖广泛、保全规则灵活，打破传统保险常规；除身故外的理赔案件均可通过线上APP 提交审核， 理赔时效有保障。 作为中国预防医学领域的领军企业，美年健康年服务客户约3000万人次，积累了覆盖全生命周期的健康大数据 ...

[Meinian Onehealth 2025 Semi-Annual Performance Forecast](index=1&type=section&id=Meinian%20Onehealth%20Healthcare%20Holdings%20Co.%2C%20Ltd.%202025%20Semi-Annual%20Performance%20Forecast) [Performance Forecast Overview](index=1&type=section&id=I.%20Current%20Period%20Performance%20Forecast) The company forecasts H1 2025 revenue between 3.96 billion and 4.20 billion yuan, with a net loss of 192 million to 236 million yuan, while AI business revenue grew 62.36% Performance Forecast Summary | Item | Current Period (2025H1) | Prior Period (2024H1) | Year-on-Year Change | | :--- | :--- | :--- | :--- | | **Operating Revenue** | 3.96 – 4.20 Billion Yuan | 4.205 Billion Yuan | Decrease 0.12% – 5.83% | | **Net Profit Attributable to Shareholders** | Loss: 192 – 236 Million Yuan | Loss: 215.7772 Million Yuan | Decrease 9.37% – Increase 11.02% | | **Net Profit Excluding Non-Recurring Items** | Loss: 205 – 253 Million Yuan | Loss: 224.5164 Million Yuan | Decrease 12.69% – Increase 8.69% | | **Basic Earnings Per Share** | Loss: 0.05 – 0.06 Yuan/Share | Loss: 0.06 Yuan/Share | - | - Main business revenue incorporating AI technologies (e.g., cardio-pulmonary joint screening, AI-MDT reports) reached **140.4159 million yuan**, a significant **62.36% increase** from the prior year[3](index=3&type=chunk) [Explanation of Performance Changes](index=1&type=section&id=III.%20Explanation%20of%20Performance%20Changes) Performance changes are mainly due to the H1 off-peak season and macroeconomic factors, causing some corporate clients to delay examinations, while the company maintained stable individual market metrics and prepared for the peak season - Macroeconomic conditions led some corporate clients to postpone budgets and medical examinations during the traditional H1 off-peak season, impacting revenue[5](index=5&type=chunk) - Overall order signing, average customer spending, and the individual examination market remained relatively stable, with ongoing efforts to convert group examination clients to individual ones[5](index=5&type=chunk) - The company made progress in cost reduction and efficiency improvement through AI and digital means in H1, laying the groundwork for the H2 peak examination season[6](index=6&type=chunk) [Other Relevant Information](index=1&type=section&id=IV.%20Other%20Relevant%20Information) This performance forecast is a preliminary, unaudited estimate from the financial department, advising investors of risks, with final data to be disclosed in the official semi-annual report - The financial data in this performance forecast is unaudited by certified public accountants[4](index=4&type=chunk) - This forecast represents preliminary estimates by the company's financial department; final accurate financial data will be disclosed in the 2025 semi-annual report[7](index=7&type=chunk)

美年健康（002044）公告，预计2025年1月1日至2025年6月30日，营业收入为39.6亿元–42亿元，比上年 同期下降0.12%-5.83%。预计归属于上市公司股东的净利润为亏损1.92亿元–2.36亿元，上年同期亏损 2.16亿元。扣除非经常性损益后的净利润预计为亏损2.05亿元–2.53亿元，上年同期亏损2.25亿元。基本 每股收益预计为亏损0.05元/股–0.06元/股，上年同期为亏损0.06元/股。 ...

Core Viewpoint - The China Securities Index for Healthcare Equipment and Services has shown a slight increase of 0.39% recently, reflecting the overall performance of listed companies in the healthcare sector [1] Group 1: Index Performance - The China Securities Index for Healthcare Equipment and Services is currently at 13,682.83 points with a trading volume of 18.089 billion [1] - Over the past month, the index has decreased by 0.83%, while it has increased by 2.95% over the last three months, and has seen a year-to-date decline of 0.43% [1] Group 2: Index Composition - The index is composed of listed companies that correspond to the healthcare theme, with a base date of December 31, 2004, set at 1,000.0 points [1] - The top ten weighted companies in the index include: Mindray Medical (9.44%), United Imaging (8.04%), Aier Eye Hospital (7.55%), Aimeike (3.41%), Huatai Medical (3.23%), New Industry (2.81%), Yuyue Medical (2.7%), Lepu Medical (2.54%), Meinian Onehealth (2.05%), and Shandong Pharmaceutical Glass (1.91%) [1] Group 3: Market Distribution - The index's holdings are primarily listed on the Shenzhen Stock Exchange (60.09%) and the Shanghai Stock Exchange (39.91%) [1] - The healthcare sector accounts for 100% of the index's holdings [1] Group 4: Index Adjustment and Fund Tracking - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2] - Public funds tracking the healthcare index include various Southern and Tianhong funds, as well as ETFs from multiple financial institutions [2]

Core Viewpoint - The company announces an adjustment in the share issuance price for asset acquisition due to the implementation of the 2024 annual dividend distribution, changing from 4.74 CNY/share to 4.73 CNY/share [1][3]. Group 1: Asset Acquisition Overview - The company plans to acquire 84% of Hengyang Meinian Health Checkup Center Co., Ltd., 81% of Ningde Meinian Health Management Co., Ltd., 75% of Yantai Meinian Health Checkup Management Co., Ltd., and several other health management companies through share issuance [1]. - The total shares to be issued for the acquisition will be priced based on the average trading price of the company's stock over the previous 120 trading days, ensuring it is not less than 80% of that average [2]. Group 2: Dividend Distribution Plan - The company will distribute a cash dividend of 0.135 CNY per 10 shares, amounting to approximately 52.84 million CNY (including tax), based on a total share capital of 3,914,253,923 shares [2][3]. - The record date for the dividend distribution is set for July 3, 2025, with the ex-dividend date on July 4, 2025 [3]. Group 3: Share Issuance Price Adjustment - Following the dividend distribution, the share issuance price for the asset acquisition will be adjusted to 4.73 CNY/share, calculated by subtracting the cash dividend of 0.0135 CNY/share from the previous price of 4.74 CNY/share [3]. - The transaction is subject to multiple approval processes, including shareholder meeting approval and regulatory review [4].

Meeting Overview - The 31st temporary meeting of the 8th Supervisory Board of Meinian Health Industry Holdings Co., Ltd. was held on July 11, 2025, via electronic means, with all three supervisors present [1][2]. Proposal for Asset Acquisition - The company plans to acquire equity stakes in 11 companies, including Hengyang Meinian Health Examination Center Co., Ltd., and minority stakes in 5 subsidiaries, including Zhengzhou Meijian Health Management Co., Ltd., through a share issuance [1][2][3]. Approval of Proposals - The Supervisory Board approved the proposal regarding the company's compliance with conditions for issuing shares to purchase assets, with a unanimous vote of 3 in favor [2][3]. - The proposal for the share issuance to purchase assets and related transactions was also approved, with a unanimous vote of 3 in favor [2][3]. Transaction Details - The transaction involves 37 counterparties, including individuals and companies, with specific equity stakes and transaction prices outlined for each [3][4]. - The transaction prices for key stakes include: - 84% of Hengyang Meinian for 33.6 million yuan - 81% of Ningde Meinian for 30.78 million yuan - 75% of Yantai Meinian for 35.8125 million yuan - 49% of Yantai Meinian Fudian for 12.25 million yuan - 90% of Feicheng Meinian for 22.5 million yuan [3][4]. Share Issuance Pricing - The share issuance price is set at 4.74 yuan per share, which is not less than 80% of the average trading price over the previous 120 trading days [5][6]. - The issuance price may be adjusted based on market conditions during the period from the pricing base date to the issuance date [6][7]. Lock-up Period and Profit Distribution - A lock-up period of 36 months is established for shares acquired by the counterparty, with conditions for extension based on stock performance [9][10]. - The profits generated during the transition period will belong to the company, while losses will be compensated by the counterparties based on their ownership percentages [10][11]. Compliance and Regulatory Approvals - The proposals will be submitted to the shareholders' meeting for approval, requiring a two-thirds majority of the voting rights present [2][11]. - The company has confirmed compliance with relevant laws and regulations regarding the asset acquisition and share issuance [12][13]. Future Shareholder Returns - The company has developed a three-year shareholder return plan for 2025-2027 to enhance shareholder value and ensure reasonable returns [26].

Meeting Announcement - The company will hold its first extraordinary general meeting of shareholders in 2025 on July 28, 2025, at 14:50 in Shanghai [1][2] - The meeting will combine on-site voting and online voting, with online voting available from 9:15 to 15:00 on the same day [1][2] Voting Procedures - Shareholders can choose either on-site voting or online voting, and duplicate votes will be counted based on the first submission [2] - Shareholders must register to attend the meeting, with specific requirements for both corporate and individual shareholders [6][7] Agenda Items - The meeting will review several proposals, including the issuance of shares for asset acquisition and related transactions [4][12] - Proposals require a two-thirds majority of valid votes from attending shareholders, with related shareholders required to abstain from voting on certain items [6][12] Compliance and Reporting - The proposals have been approved by the company's board and supervisory committee, and details were published in various financial news outlets [5][12] - The company will ensure compliance with relevant regulations regarding asset restructuring and share issuance [5][13]

Core Viewpoint - The company has established a three-year shareholder return plan for 2025-2027 to ensure a scientific, sustainable, and stable dividend mechanism, aiming to protect investors' reasonable returns [1][2]. Group 1: Considerations for the Plan - The plan is based on long-term sustainable development, considering factors such as profitability, investment needs, cash flow, shareholder returns, social capital costs, and external financing environment [1]. - The plan emphasizes the importance of listening to shareholders, especially minority shareholders, and ensuring their legal rights while balancing the company's long-term interests [1][2]. Group 2: Specific Content of the Plan - The company may distribute dividends in cash, stock, or a combination of both, prioritizing cash dividends when conditions are met [2]. - Cash dividend conditions include having positive profits and not exceeding certain thresholds for major investments or cash expenditures [2][3]. - Stock dividends can be proposed when the company's operational status is good, and the board believes it benefits all shareholders, provided cash dividend conditions are met [2]. Group 3: Dividend Distribution Principles - The company aims to distribute at least 20% of the distributable profits as cash dividends annually, with adjustments for previous losses [3][5]. - The board will consider industry characteristics, development stages, and significant capital expenditure plans when proposing differentiated cash dividend policies [3][4]. Group 4: Decision-Making Mechanism - The board will review the shareholder return plan every three years and adjust the dividend distribution policy as necessary, based on current profitability, cash flow, and funding needs [5][6]. - The plan requires thorough discussion and approval from the board, supervisory board, and shareholders, ensuring transparency and communication with minority shareholders [5][6]. Group 5: Implementation of the Plan - The company is committed to executing the shareholder return plan effectively, with oversight from the supervisory board to ensure compliance and address any deviations from the proposed dividend policies [6][7].